证券代码：688607 证券简称：康众医疗 公告编号：2025-049 江苏康众数字医疗科技股份有限公司 关于首次公开发行股票募集资金投资项目结项并将节 余募集资金永久补充流动资金及投入研发项目的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次结项的募投项目名称：平板探测器生产基地建设项目、研发服务中 心建设项目。 本次节余募集资金金额合计为 7,364.95 万元（不含期间利息及理财收 益），募集资金使用金额中含待支付尾款 3,514.85 万元，公司拟将上述节余募 集资金 3,000.00 万元投入"新一代平板探测器设计与制造技术"研发项目、 4,364.95 万元永久补充流动资金。 | 结项名称 | 募集资金承诺使 | 募集资金实际使 | 待支付尾款金额 | 预计节余募集资金金 | | --- | --- | --- | --- | --- | | | 用金额（A） | 用金额（B） | （C） | 额（D）D=A-B-C | | 平板探测器 | | | | | | 生产基地建 | 21,386 ...

Core Viewpoint - Kangzhong Medical (688607.SH) has announced the conclusion of its fundraising projects and the allocation of surplus funds for operational and R&D purposes [1] Group 1: Fundraising Projects - The company held its 13th (temporary) meeting of the third board on December 29, 2025, to review and approve the conclusion of its initial public offering fundraising projects [1] - The projects concluded include the "Flat Panel Detector Production Base Construction Project" and the "R&D Service Center Construction Project" [1] Group 2: Surplus Fund Allocation - The total amount of surplus fundraising is 73.6495 million yuan (excluding interest and financial income) [1] - Of the total fundraising amount, 35.1485 million yuan is pending payment [1] - The company plans to allocate 30 million yuan to the "Next Generation Flat Panel Detector Design and Manufacturing Technology" R&D project and 43.6495 million yuan to permanently supplement working capital [1]

Market Overview - The medical device sector experienced a decline of 0.74% on December 29, with Huakang Clean leading the drop [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] Top Performers - Meihao Medical (301363) saw a closing price of 25.04, with an increase of 8.30% and a trading volume of 197,100 shares, totaling a transaction value of 482 million yuan [1] - Mailande (688273) closed at 41.73, up 8.22%, with a trading volume of 55,200 shares and a transaction value of 227 million yuan [1] - Kangzhong Medical (688607) closed at 45.80, up 7.23%, with a trading volume of 40,200 shares and a transaction value of 180 million yuan [1] Underperformers - Huakang Clean (301235) closed at 39.21, down 8.54%, with a trading volume of 123,300 shares and a transaction value of 488 million yuan [2] - C Jianxin (688805) closed at 47.16, down 7.26%, with a trading volume of 89,000 shares and a transaction value of 426 million yuan [2] - Furuim Medical (300049) closed at 71.93, down 4.20%, with a trading volume of 66,800 shares and a transaction value of 485 million yuan [2] Capital Flow - The medical device sector saw a net outflow of 565 million yuan from institutional investors, while retail investors experienced a net inflow of 328 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Meihao Medical (301363) had a net outflow of 54.30 million yuan from institutional investors, with retail investors also showing a net outflow of 0.76 million yuan [3] - Jigaofazhan (600807) experienced a net inflow of 44.75 million yuan from institutional investors, while retail investors had a net outflow of 61.29 million yuan [3] - Kangzhong Medical (688626) saw a net inflow of 44.26 million yuan from institutional investors, with retail investors showing a slight net outflow [3]

Core Viewpoint - The company is actively focusing on the research and development of new technologies, including AI, and is expanding its product offerings in this area [1] Group 1: Company Initiatives - The company has introduced several products and services related to AI, including intelligent beamers, intelligent DR solutions, and AI-based grassroots medical diagnostics [1]

Group 1 - The medical device sector increased by 0.56% on December 19, with Kangzhong Medical leading the gains [1] - The Shanghai Composite Index closed at 3890.45, up 0.36%, while the Shenzhen Component Index closed at 13140.22, up 0.66% [1] - Notable gainers in the medical device sector included Kangzhong Medical, which rose by 7.36% to a closing price of 44.90, and Rendu Biotech, which increased by 6.78% to 50.40 [1] Group 2 - The medical device sector experienced a net inflow of 3.65 million yuan from institutional investors, while retail investors saw a net inflow of 15 million yuan [2] - Major stocks with significant net inflows included Rejing Bio with 49.71 million yuan and Yuyue Medical with 43.84 million yuan [3] - Conversely, retail investors showed net outflows in several stocks, including Yuyue Medical and Mairui Medical, indicating a mixed sentiment in the market [3]

证券之星消息，12月12日医疗器械板块较上一交易日上涨0.84%，康众医疗领涨。当日上证指数报收于 3889.35，上涨0.41%。深证成指报收于13258.33，上涨0.84%。医疗器械板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 从资金流向上来看，当日医疗器械板块主力资金净流入9755.48万元，游资资金净流出1.95亿元，散户资 金净流入9728.32万元。医疗器械板块个股资金流向见下表： ...

从资金流向上来看，当日医疗器械板块主力资金净流出4.22亿元，游资资金净流入1.29亿元，散户资金 净流入2.93亿元。医疗器械板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 证券之星消息，12月9日医疗器械板块较上一交易日下跌0.95%，康众医疗领跌。当日上证指数报收于 3909.52，下跌0.37%。深证成指报收于13277.36，下跌0.39%。医疗器械板块个股涨跌见下表： ...

中信证券股份有限公司 关于江苏康众数字医疗科技股份有限公司 股东向特定机构投资者询价转让股份的核查报告 上海证券交易所： 中信证券股份有限公司（以下简称"中信证券"或"组织券商"）受委托担 任畅城有限公司、霍尔果斯君联承宇创业投资有限公司（以下合称"转让方"） 以向特定机构投资者询价转让（以下简称"询价转让"）方式减持所持有的江苏 康众数字医疗科技股份有限公司（以下简称"公司"或"康众医疗"）首次公开 发行前已发行股份的组织券商。 经核查，中信证券就本次询价转让的股东、受让方是否符合《上海证券交易 所科创板上市公司自律监管指引第 4 号——询价转让和配售（2025 年 3 月修订）》 （以下简称"《询价转让和配售指引》"）要求，本次询价转让的询价、转让过 程与结果是否公平、公正，是否符合《询价转让和配售指引》的规定作出如下报 告说明。 一、本次询价转让概况 （一）本次询价转让转让方 截至 2025 年 11 月 28 日，转让方所持公司首发前股份的数量及占公司总股 本比例情况如下： | 序号 | 股东名称 | 持股数量（股） | 持股比例 | | | --- | --- | --- | --- | --- | ...

证券代码：688607 证券简称：康众医疗 公告编号：2025-047 江苏康众数字医疗科技股份有限公司 股东询价转让结果报告书暨持股 5%以上股东权益变动 降至 5%以下的提示性公告 畅城有限公司、霍尔果斯君联承宇创业投资有限公司（以下合称"转让方" "畅城有限公司及其一致行动人"）保证向江苏康众数字医疗科技股份有限公司 （以下简称"康众医疗"或"公司"）提供的信息内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其真实性、准确性和完整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示: 本次询价转让的价格为28.22元/股，转让的股票数量为4,100,000股。 畅城有限公司、霍尔果斯君联承宇创业投资有限公司参与本次询价转让。 本次权益变动为股份减持。本次转让不会导致公司控股股东、实际控制 人发生变化。 本次权益变动后， 畅城有限公司及其一致行动人持有公司股份比例由 9.53%减少至4.88%，持有公司权益比例降至 5%以下并触及 1%的整数倍。 一、转让方情况 （一）转让方基本情况 截至 2025 年 11 月 28 日转让方所持公司股份的数量、比 ...

证券代码：688607 证券简称：康众医疗 公告编号：2025-048 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 一、 信息披露义务人及其一致行动人的基本信息 1.身份类别 | | □控股股东/实际控制人及其一致行动人 | | --- | --- | | | ☑其他 5%以上大股东及其一致行动人 | | 投资者及其一致行动人的身份 | □合并口径第一大股东及其一致行动人（仅适用 | | | 于无控股股东、实际控制人） | | | □其他______________（请注明） | 2.信息披露义务人信息 | 信息披露义务人名称 | | 投资者身份 | 统一社会信用代码 | | --- | --- | --- | --- | | | □ | 控股股东/实控人 | | | 财通基金玉泉2009号 | □ | 控股股东/实控人的一致 | □ | | 单一资产管理计划 | 行动人 | | 不适用 ☑ | | | ☑ | 其他直接持股股东 | | 重要内容提示： 权益变动方向 比例增加☑ 比例减少□ 权益变动前合计比例 10.17% 权益变动后合计比例 12.11% 本次变动是否违反已作出的承 ...